SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-16-033552
Filing Date
2016-06-08
Accepted
2016-06-08 19:33:18
Documents
1
Period of Report
2016-06-06

Document Format Files

Seq Description Document Type Size
1 SIECZKAREK rdgdoc.html 4  
1 SIECZKAREK rdgdoc.xml 4 4252
  Complete submission text file 0001437749-16-033552.txt   5508
Mailing Address
Business Address
SIECZKAREK MARK M (Reporting) CIK: 0001188738 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33678 | Film No.: 161704687

Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Issuer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations